Stock Earnings

Question 1

What are Avalo Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Avalo Therapeutics Inc has a total asset of $151, Net loss of $-35

Question 2

What are the key financial ratios for AVTX?

Accepted Answer

Avalo Therapeutics Inc's Current ratio is 8.38, has a Net margin is 0, sales per share of $0.

Question 3

How is Avalo Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Avalo Therapeutics Inc largest revenue segment is Pharmaceutical, at a revenue of 1,408,000 in the most earnings release.For geography, United States is the primary market for Avalo Therapeutics Inc, at a revenue of 1,924,000.

Question 4

Is Avalo Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Avalo Therapeutics Inc has a net loss of $-35

Question 5

Does Avalo Therapeutics Inc have any liabilities?

Accepted Answer

yes, Avalo Therapeutics Inc has liability of 18

Question 6

How many outstanding shares for Avalo Therapeutics Inc?

Accepted Answer

Avalo Therapeutics Inc has a total outstanding shares of 10

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	1	18	5	6
Revenue Growth (YoY)	--	-100%	-94%	260%	-17%	0%
Cost of Revenue	--	0	1	3	1	0
Gross Profit	--	0	0	14	3	6
Selling, General & Admin	21	17	10	20	24	19
Research & Development	21	24	13	31	59	32
Operating Expenses	67	41	23	52	86	53
Other Non Operating Income (Expenses)	-26	33	0	0	0	0
Pretax Income	-100	-35	-32	-41	-84	-67
Income Tax Expense	0	0	0	0	0	-2
Net Income	-100	-35	-32	-41	-84	-63
Net Income Growth	186%	9%	-22%	-51%	33%	294%
Shares Outstanding (Diluted)	14	4.43	0.28	9.41	8.32	5.56
Shares Change (YoY)	27%	1,482%	-97%	13%	50%	56%
EPS (Diluted)	-7.14	-7.9	-114.28	-4.43	-10.13	-11.42
EPS Growth	122%	-93%	2,480%	-56%	-11%	154%
Free Cash Flow	-52	-49	-31	-26	-71	-40
Free Cash Flow Per Share	-3.71	-11.06	-110.71	-2.76	-8.53	-7.19
Gross Margin	--	0%	0%	77.77%	60%	100%
Operating Margin	0%	0%	-2,300%	-205.55%	-1,639.99%	-783.33%
Profit Margin	0%	0%	-3,200%	-227.77%	-1,680%	-1,050%
Free Cash Flow Margin	0%	0%	-3,100%	-144.44%	-1,420%	-666.66%
EBITDA	-66	-41	-23	-37	-81	-46
EBITDA Margin	0%	0%	-2,300%	-205.55%	-1,620%	-766.66%
D&A For EBITDA	0	0	0	0	1	1
EBIT	-66	-41	-23	-37	-82	-47
EBIT Margin	0%	0%	-2,300%	-205.55%	-1,639.99%	-783.33%
Effective Tax Rate	0%	0%	0%	0%	0%	2.98%

Avalo Therapeutics Inc (AVTX) Price

AVTX Stock Price Chart

AVTX Income

Follow-Up Questions